Local immune response predicts survival in patients with thick (t4) melanomas (Q44512595)

3 December 2017

title

Local immune response predicts survival in patients with thick (t4) melanomas (English)

1 reference

3 December 2017

main subject

local immune response

1 reference

11

Brian J Czerniecki

1 reference

3 December 2017

12

Giorgos Karakousis

1 reference

3 December 2017

9

Douglas Fraker

1 reference

3 December 2017

Jessica A Cintolo

1

1 reference

3 December 2017

Phyllis Gimotty

2

1 reference

3 December 2017

Anne Blair

3

1 reference

3 December 2017

Dupont Guerry

4

1 reference

3 December 2017

David E Elder

5

1 reference

3 December 2017

Rachel Hammond

6

1 reference

3 December 2017

Rosalie Elenitsas

7

1 reference

3 December 2017

Xiaowei Xu

8

1 reference

3 December 2017

Lynn M Schuchter

10

1 reference

3 December 2017

publication date

10 July 2013

1 reference

Annals of Surgical Oncology

3 December 2017

published in

1 reference

3 December 2017

volume

20

1 reference

3 December 2017

issue

11

1 reference

3 December 2017

page(s)

3610-3617

1 reference

Final version of 2009 AJCC melanoma staging and classification

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

Prognostic factors for melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

Mechanisms of local immunosuppression in cutaneous melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

Melanoma vaccines: The problems of local immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

Toward prediction of immune mechanisms and design of immunotherapies in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

Comparison of prognostic factors for survival and recurrence in malignant melanoma of the skin, clinical Stage I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

Model predicting survival in stage I melanoma based on tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

The correlation of regression in primary melanoma with sentinel lymph node status

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

Regression in malignant melanoma. A histologic feature without independent prognostic significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

Cutaneous melanoma: estimating survival and recurrence risk based on histopathologic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

High Lymphatic Vessel Density and Lymphatic Invasion Underlie the Adverse Prognostic Effect of Radial Growth Phase Regression in Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

The critical role of Th1-dominant immunity in tumor immunology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

Effector memory T cells, early metastasis, and survival in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

Foxp3 expressing CD4 CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

Tumor-infiltrating γδ T lymphocytes predict clinical outcome in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

Prognostic impact of FoxP3 regulatory T cells in relation to CD8 T lymphocyte density in human colon carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

Immunosuppressive strategies that are mediated by tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

Differentiation and gene expression profile of tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

Th17 cells: positive or negative role in tumor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

White Paper on Adoptive Cell Therapy for Cancer with Tumor-Infiltrating Lymphocytes: A Report of the CTEP Subcommittee on Adoptive Cell Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

CD8 Enriched “Young” Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

Phase I study of adoptive T-cell therapy using antigen-specific CD8 T cells for the treatment of patients with metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

Matrix metalloproteinase-2 conditions human dendritic cells to prime inflammatory T(H)2 cells via an IL-12- and OX40L-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1245/S10434-013-3086-3

10.1245/S10434-013-3086-3

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

3 December 2017

1022814042

0 references

1 reference